Abstract
Transparency and accountability are becoming more important, and publically reported quality measures will be used increasingly to determine how surgeons are viewed and reimbursed. That is a good thing if it is done correctly, but poorly designed quality measures might actually interfere with patient care. It will be necessary for ASBrS to remain involved in the development of relevant, true data-based measures of quality that have appropriate benchmarks and no unintended consequences. Importantly, the quality measures need to include all reasonable treatment options so that quality care is enhanced and not impeded.
Similar content being viewed by others
References
Fyles AW, McCready DR, Manchul LA et al (2004) Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med. 351:963–970.
Sams F (1988) The passing: perspectives of rural America. Marietta: Longstreet Press, pp 61–64.
Fisher B, Montague E, Redmond C (1977) Comparison of radical mastectomy with alternative treatments for primary breast cancer: a first report of results from a prospective randomized clinical trial. Cancer. 39:2827–2839.
Bruce J (1971) Operable cancer of the breast: a controlled clinical trial. Cancer. 28:1443–1451.
Deutsch M, Land S, Begovic M et al (2008) The incidence of arm edema in women with breast cancer randomized on the National Surgical Adjuvant Breast and Bowel Project study B-04 to radical mastectomy versus total mastectomy and radiotherapy versus total mastectomy alone. Int J Radiat Oncol Biol Phys. 70:1020–1024.
Bonadonna G, Brusamolino E, Valagussa P et al (1975) Adjuvant study with combination chemotherapy in operable breast cancer. Proc Am Assoc Cancer Res Am Soc Clin Oncol. 16:254(abstr 1135).
Haffty BG, Fischer D, Fischer J (1990) Regional nodal irradiation in the conservative treatment of breast cancer. Int J Radiol Oncol Biol Phys. 19:859–865.
Recht A, Houlihan MJ (1995) Axillary lymph nodes and breast cancer. Cancer. 76:1491–1512.
Galper S, Recht A, Silver B et al (2000) Is radiation alone adequate treatment to the axilla for patients with limited axillary surgery? Implications for treatment after a positive sentinel node biopsy. Int J Radiol Oncol Biol Phys. 48:125–132.
Chua B, Ung O, Boyages J (2001) Treatment of the axilla in early breast cancer: past, present and future. ANZ J Surg. 71:729–736.
Veronesi U, Orecchia R, Zurrida S et al (2005) Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy. Ann Oncol. 16:383–388.
Pejavar S, Wilson LD, Haffty BG (2006) Regional nodal recurrence in breast cancer patients treated with conservative surgery and radiation therapy (BCS + RT). Int J Radiol Oncol Biol Phys. 66:1320–1327.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Snider, H. American Society of Breast Surgeons Presidential Address: Could Quality Measures Impede Quality Care?. Ann Surg Oncol 19, 3125–3130 (2012). https://doi.org/10.1245/s10434-012-2481-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-012-2481-5